IW Homepage Web Watch Resources Web Links Thought Leaders Site Search Contact Us
About Newsletter Contributors Multimedia Clips Futurepedia Podcast David Forrest's Blog
Join the Innovation Watch community... read and post in our online forums (coming soon) Innovation Forums
   Books on the Future and Emerging Trends -
   Bio and Nanotechnology
 HOME
 Resources
 The Future and
 Emerging Trends
 
 Foresight
 Science
 Technology
 Society
 Economy
 Global Politics
 Environment
 Possible Futures
 Making Change

The Second Creation: Dolly and the
Age of Biological Control

by Ian Wilmut, Keith Campbell and Colin Tudge

New York: Farrar, Strauss and Giroux, 2000

Human cloning has grabbed people's imagination, but that is merely a diversion -- and one we personally regret and find distasteful. We did not make Dolly for that…Our work completes the biotechnological trio: genetic engineering, genomics, cloning. It also provides an extraordinarily powerful scientific model for studying the interactions of the genes and their surroundings -- interactions that account for so much of development and disease. Taken together, the new biotechnologies and the pending scientific insights will be immensely powerful. Truly they will take humanity into the age of biological control.

The cloning of Dolly in 1996 from the cell of an adult sheep was a pivotal moment in history. For the first time, a team of scientists, led by Ian Wilmut and Keith Campbell at the Roslin Institute near Edinburgh, was able to clone a whole mammal using a single cultured adult body cell, a breakthrough that revolutionized three technologies and brought science ever closer to the possibility of human cloning.

In this definitive account, the scientists who accomplished this stunning feat explain their hypotheses and experiments, their conclusions, and the implications of their work. Researchers have already incorporated into sheep the gene for human factor 1X, a blood-clotting protein used to treat hemophilia. In the future, cultures of mammary cells may prove to be valuable donor material, and genetically modified animal organs may be transplanted into humans. Normal pig organs, for example, are rapidly destroyed by the human immune system, but if altered genetically, they could alleviate the serious shortage of available organs. Genetically engineered sheep are also expected to be valuable as models for genetic defects that mimic human disorders such as cystic fibrosis, and for cell-based therapies for diseases -- such as Parkinson's, diabetes, and muscular dystrophy -- that lack universally dependable treatments.

But what are the ethical issues raised by this pioneering research, and how are we to reconcile them with the enormous possibilities? Written with award-winning science writer Colin Tudge, The Second Creation is a landmark work that details the most exciting and challenging scientific discovery of the twentieth century -- with the furthest-reaching ramifications for the twenty-first.

Ian Wilmut studied embryology at Nottingham University and received his doctoral degree at Cambridge University before joining the Animal Breeding Research Station, an independent research institution that eventually became the Roslin Institute. He was the leader of the team that cloned Dolly.

Keith Campbell studied microbiology at Queen Elizabeth College, London, and obtained a D. Phil. From The University of Sussex. A cell biologist and embryologist now working at the University of Nottingham, he joined the Roslin Institute in 1991 to work on the project that resulted in Dolly.

Colin Tudge was educated at Cambridge University, where he majored in zoology. A writer and broadcaster, he is also a Research Fellow at the Centre for Philosophy at the London School of Economics. Tudge is the author of more than a dozen books, including most recently, The Variety of Life: A Survey and a Celebration of All the Creatures That Have Ever Lived, published by Oxford University Press.

 

 
   
IW Homepage | Web Watch | Resources | Web Links | Thought Leaders | Site Search | Contact Us
About | Newsletter | Contributors | Multimedia Clips | Futurepedia | Podcast | David Forrest's Blog
Join the Innovation Watch community... read and post in our online forms: Innovation Forums
Send mail to mail (at) innovationwatch.com with questions or comments about this site.
Copyright © 2001-2009. Innovation Watch is a registered trademark.